Sale

Erythropoietin Drugs Market

Global Erythropoietin Drugs Market Size, Share, Growth, Trends, Forecast: By Drug Type: Biologics, Biosimilars; By Product Type: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others; By Application: Hematology, Kidney Disorder, Cancer, Others; By End User: Hospitals, Homecare, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Erythropoietin Drugs Market Outlook

The global erythropoietin drugs market was valued at USD 10.89 billion in 2023, driven by the increasing prevalence of chronic kidney diseases and diabetes, cancer across the globe. The market size is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 to achieve a value of USD 17.93 billion by 2032.

 

Erythropoietin Drugs: Introduction

Erythropoietin is a hormone solely produced by the kidneys in a human body. This hormone helps in generating enough erythrocytes (red blood cells) in body by delivering proper amount of oxygen among body tissues. When this oxygen turns into energy, carbon dioxide releases. Red blood cells are also responsible for delivering carbon dioxide to the lung to exhale it out of the body. Usually, when low oxygen levels are encountered, the specialized cells located in the kidneys boosts the production of Erythropoietin.

 

Global Erythropoietin Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Trends in the Erythropoietin Drugs Market

These drugs are widely used for the treatment of anemia, kidney diseases, cancer, and patients undergoing chemotherapies or dialysis. These drugs can be consumed in the form of injections or subcutaneous implants. Stimulation of bone marrow helps erythropoietin drugs to produce more red blood cells, resulting in improved capacity of carrying oxygen, and relieve the symptoms related with anemia.

 

There are several key trends running in the market and some of them include the rising prevalence of chronic kidney diseases. The rise in ageing population is causing increased prevalence of diabetes and hypertension, leading to higher demand for erythropoietin drugs. Along with it, the increasing use of these drugs in oncology, advancements in drug delivery systems, expiration of biosimilars and patents are also among the key trends aiding the market growth.

 

Erythropoietin Drugs Market Segmentations

 

Global Erythropoietin Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Drug Type

  • Biologics 
  • Biosimilars

 

Market Breakup by Product Type

  • Epoetin-alfa 
  • Epoetin-beta 
  • Darbepoetin-alfa 
  • Others

 

Market Breakup by Application

  • Haematology 
  • Kidney Disorder 
  • Cancer 
  • Others

 

Erythropoietin Drugs Market Scenario

The global market size for erythropoietin drugs has been constantly growing and is expected to witness gradual growth in future as well. The increasing prevalence of anaemia and increasing demand for biosimilar and biological drugs are directly contributing to the growth of market size. The major cause of anaemia such as unhealthy diets and increasing chronic diseases, along with intestinal issues, and some other infections are increasing the demand for biosimilar drugs, and directly contributing to the growth of the erythropoietin drugs market size.

 

Global Erythropoietin Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Due to the increasing rate of development of anaemia in more people the demand for erythropoietin drugs has also increased as they are approved by healthcare professionals easily and the research authorities. These fast approvals result in increased availability and increased production of the drug to directly support the growth of the erythropoietin drug market size.

 

Competitor landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Biocon Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG 
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson
  • LG Chem Ltd.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited 
  • Teva Pharmaceutical Industries Ltd
  • Amgen Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Type 
  • Product Type
  • Application
  • End User
  • Region
Breakup by Drug Type 
  • Biologics 
  • Biosimilars
Breakup by Product Type
  • Epoetin-alfa 
  • Epoetin-beta 
  • Darbepoetin-alfa 
  • Others
Breakup by Application
  • Haematology 
  • Kidney Disorder 
  • Cancer 
  • Others
Breakup by End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Amgen Inc.
  • Biocon Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG 
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson
  • LG Chem Ltd.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited 
  • Teva Pharmaceutical Industries Ltd

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Erythropoietin Drugs Market Overview 

    3.1    Global Erythropoietin Drugs Market Historical Value (2017-2023) 
    3.2    Global Erythropoietin Drugs Market Forecast Value (2024-2032)
4    Global Erythropoietin Drugs Market Landscape
    4.1    Image Guided Surgery: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Image Guided Surgery: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
5    Global Erythropoietin Drugs Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Erythropoietin Drugs Market Segmentation
    6.1    Global Erythropoietin Drugs Market by Drug Type 
        6.1.1    Market Overview
        6.1.2    Biologics
        6.1.3    Biosimilars
    6.2    Global Erythropoietin Drugs Market by Product Type
        6.2.1    Market Overview
        6.2.2    Epoetin-alfa
        6.2.3    Epoetin-beta
        6.2.4    Darbepoetin-alfa
        6.2.5    Others
    6.3    Global Erythropoietin Drugs Market by Application
        6.3.1    Market Overview
        6.3.2    Hematology
        6.3.3    Kidney Disorder
        6.3.4    Cancer
        6.3.5    Others
    6.4    Global Erythropoietin Drugs Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Homecare
        6.4.4    Specialty Clinics
        6.4.5    Others
    6.5    Global Erythropoietin Drugs Market by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Erythropoietin Drugs Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Erythropoietin Drugs Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Erythropoietin Drugs Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Erythropoietin Drugs Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Erythropoietin Drugs Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Amgen Inc. 
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications 
    18.2    Biocon Limited
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Dr. Reddy’s Laboratories Ltd.
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    F. Hoffmann-La Roche AG 
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Intas Pharmaceuticals Ltd. 
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Johnson & Johnson
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    LG Chem Ltd. 
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Pfizer Inc.
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Sun Pharmaceutical Industries Limited 
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Teva Pharmaceutical Industries Ltd.
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket
    
    
*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global market was valued at USD 10.89 billion in 2023.

The global erythropoietin market size is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 and reach a market value of USD 17.93 billion by 2032.

The rising incidence and prevalence of chronic kidney disease and cancer worldwide are the major drivers for the global erythropoietin market.

The different types of drugs in the market are biologics and biosimilars.

The different type of products in the market includes epoetin-alfa, epoetin-beta, and darbepoetin-alfa, among others.

The end users of the erythropoietin drugs include hospitals, homecare, and speciality clinics, among others.

The different applications of erythropoietin drugs include haematology, kidney disorder, cancer, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The key players involved in the market are Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Limited.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER